Kaletra (HIV)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 7
3 Disease Overview 9
3.1 Etiology and Pathophysiology 9
3.1.1 Etiology 9
3.1.2 Pathophysiology 12
3.1.3 Prognosis 12
3.1.4 Quality of Life 13
3.2 Symptoms 13
3.2.1 Primary or Acute Infection 13
3.2.2 Chronic Infection 13
3.2.3 Advanced Infection/AIDS 14
4 Disease Management 15
4.1 Treatment Overview 15
5 Competitive Assessment 19
5.1 Overview 19
5.2 Strategic Competitor Assessment 19
6 Kaletra (lopinavir/ritonavir) 22
6.1 Overview 22
6.2 Efficacy 24
6.3 Safety 24
6.4 SWOT Analysis 24
6.5 Forecast 26
7 Appendix 27
7.1 Bibliography 27
7.2 Abbreviations 29
7.3 Methodology 31
7.4 Forecasting Methodology 31
7.4.1 HIV Prevalence 31
7.4.2 Percent Drug-Treated Patients 31
7.4.3 General Pricing Assumptions 32
7.4.4 Individual Drug Assumptions 33
7.4.5 Generic Erosion 33
7.5 Physicians and Specialists Included in this Study 34
7.5.1 Survery of Prescribing Physicians 35
7.6 About the Authors 35
7.6.1 Authors 35
7.6.2 Global Head of Healthcare 36
7.7 About GlobalData 37
7.8 Contact Us 37
7.9 Disclaimer 37